Ruffolo Robert R
- SEC CIK
- 0001187308
No open-market purchases or sales filed in the past year.
Current role at each company
- ELTX Elicio Therapeutics, Inc.Directoras of Sep 2, 2026
- LBRX LB Pharmaceuticals IncDirectoras of Jun 5, 2026
- SGTX Sigilon Therapeutics, Inc.Directoras of Aug 11, 2023
- ARDS Aridis Pharmaceuticals, Inc.Directoras of Dec 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ruffolo Robert R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SGTX Sigilon Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Ruffolo Robert RDirector | SSale | −6.75K | $10.36 | −$69.9K | −100.0%0 after |